Search in the Abstract Database

Abstracts Search 2019

N19 Validity of a Korean Version of inflammatory bowel disease–fatigue scale

S. H. Lee1, E. S. Kim2, H. D. Kim*3

1Kyungpook National University, College of Nursing, Daegu, South Korea, 2Kyungpook National University Hospital, Division of Gastroenterology, Department of Internal Medicine, Daegu, South Korea, 3Keimyung College University, Department of Nursing, Daegu, South Korea


Fatigue is one of the main symptoms of inflammatory bowel disease (IBD)

and is frequently reported by people in both active and remission disease. The incidence of inflammatory bowel disease (IBD) is rapidly increasing in Korea. However, there is no disease-specific tool to measure fatigue in Korea. This study was a methodological research implemented to evaluate the validity of the Koreans version of Inflammatory bowel disease fatigue scale (IBD-F) for use with IBD patient .


A cross-sectional descriptive study was used with 220 patients with Crohn’s and ulcerative colitis. Bilingual nursing professor, medical doctor and clinical nurse specialist performed translations and reverse translation. Content validity, construct validity, concurrent validity and reliability were conducted. To assess the concurrent validity, the correlation coefficients between the Korean version of IBD-F and IBDQ were calculated.


Preliminary analysis process of exploratory factor analysis to examined KMO measure (0.905) and Bartlett's test of sphericity was carried out(p < .000). Principal component analysis with varimax rotation was used. Only factors with an eigen value great than 1 were extracted. Three factors (12 ‘daily life’ question, 3 ‘close relationship’ question, and 2 ‘social life’ questions)were identified, explaining 74% of the variance. Concurrent validity tested with quality of life for IBD was analysed with Pearson’s Correlation Coefficient(r = 0.602, p ≤ 000). Internal consistency reliability tested with Cronbach’s ⍺ = 0.825.


This findings show that the Korean version of the IBD-F is reliable and valid for evaluating empowerment in patient with IBD, Crohn’s disease and ulcerative colitis in Korea